Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) has issued an update.
Clarity Pharmaceuticals Ltd has announced that TM Ventures Pty Ltd has ceased to be a substantial holder in the company as of August 1, 2025. This change is due to a series of on-market trades and a dilution event resulting from a capital raise by Clarity Pharmaceuticals Ltd, impacting the voting securities held by TM Ventures.
The most recent analyst rating on (AU:CU6) stock is a Buy with a A$8.20 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Average Trading Volume: 3,098,329
Technical Sentiment Signal: Buy
Current Market Cap: A$1.4B
See more data about CU6 stock on TipRanks’ Stock Analysis page.